In conclusion, our results confirm the pivotal protective role of tumor infiltrating CD8+ T cells in NSCLC and in addition show that their effect is particularly apparent when the tumor cells retain the expression of classical HLA class I and do not express the non-classical molecule HLA-E. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.